Psychadelics: Panacea of Pandora’s Box?

April 27, 2023
Phil Walls, RPh
Chief Clinical Officer, myMatrixx
background image

In this week's episode, Phil Walls explores the definition of psychedelics, which includes drugs such as LSD, psilocybin, ketamine and esketamine. He explains the differences in the chemical compositions of these drugs and how they can be used medically or recreationally.

Phil speaks about the use of psychedelics and hallucinogens, including older and more recently developed drugs. While LSD and psilocybin are classified as Schedule 1 drugs and have abuse potential, drugs like esketamine are available as Spravato nasal spray for prescription use in treating mental disorders.

The conversation also delves into the abuse potential of psychadelics and the ongoing research regarding their therapeutic uses.

*The views and opinions expressed in the Public Risk Management Association (PRIMA) blogs/podcasts are those of each respective author/speaker. The views and opinions do not necessarily reflect the official policy or position of PRIMA.*

Phil Walls, RPh
Chief Clinical Officer, myMatrixx

Responsibilities

Phil is the chief clinical officer for myMatrixx. He joined the company in 2006 and oversees all aspects of myMatrixx’s clinical program, including drug utilization review, formulary management, drug regimen reviews and targeted intervention with prescribing physicians.

Business Experience

Phil is a clinical pharmacist with over 40 years of experience in pharmacy, healthcare informatics and workers’ compensation. Previously, he served in leadership positions within the industry with Health Information Designs, Inc., PMSI and Cigna Healthcare of Florida, Inc. He is a published author and frequent national speaker on clinical issues in workers’ compensation.

Professional Affiliations

Phil was named CompPharma’s 2015 Person of the Year and received the Dorland Health People Pharmacist Award. He is a member of the AMCP, APhA, APS, ASAP, ASHP, FPA and the International Society for Pharmacoeconomics and Outcomes Research.

Education

Phil received his Bachelor of Science in pharmacy from Mercer University School of Pharmacy and was awarded doctoral candidate status in pharmacology at Ohio State University.

Sign Up for Our Education Newsletter

You Might Also Be Interested In

Blog
Hackers on the Horizon: Why Cybersecurity Funding Can’t Wait

The dynamic nature of the cyber threat landscape demands that public service organizations have a comprehensive understanding of evolving risks. Cybercriminals continually refine their methods, from ransomware attacks that encrypt critical data to stealthy data breaches that compromise sensitive information.

Read More
Podcast
What is at Risk? The Importance of Accurate Property Values

In this this week’s episode, we introduce a discussion on the critical role of accurate property appraisals in risk management, featuring insights from Natalia Szubbocsev.

Read More
Blog
Enterprise Risk Management: Lessons Learned from Captain Jean-Luc Picard and Spock

If you are responsible for the ERM function in your organization, particularly if you are like me and were involved in creating the function from the ground up, you will likely appreciate the analogies here. Whether your organization is comprised of 10 people or 10,000, public, private or non-profit, the financial sector, healthcare or higher education, there is often a common denominator; change is hard.

Read More